Vnitr Lek 2014, 60(9):757-763
Glycemic variability and continuous monitoring of glycemia
- III. interní klinika 1. LF UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA
Blood glucose levels are not constant in ther human body even in physiological status. It fluctuates depending on food intake, exercise, psychological and other factors. Normally it fluctuates between 3.9 to 7.5 mmol/l and in fasting in the standard conditions it does not exceed even more narrow range 3.9 to 5.5 mmol/l. Fluctuations are more pronounced in patient with diabetes. Hyperglycemia is a common and basic pathology in diabetes, however, antidiabetic drug often cause hypoglycemia, both increasing the range for glucose fluctuations. The level of glucose fluctuation is called glycemic variability (GV). Glycemic variability is now a favorite target of scientific research in diabetology. Increased glycemic variability is associated with hypoglycemia, possibly may contribute to chronic diabetes complications and negatively influences quality of life of diabetic patients. Last but not least, thanks to the new technology of continuous glucose monitoring, we can better describe and measure it. Finally, glycemic variability emerges as a potentially important therapeutical target.
Keywords: continuous glucose monitoring; glycemic variability; insulin pump; sensor augmented pump
Received: July 6, 2014; Accepted: July 17, 2014; Published: September 1, 2014 Show citation
References
- Siegelaar SE et al. Glucose variability; does it matter? Endocr Rev 2010; 31(2): 171-182.
Go to original source...
Go to PubMed...
- Sechterberger MK, Luijf YM, Devries JH. Poor agreement of computerized calculators for mean amplitude of glycemic excursions. Diabetes Technol Ther 2014; 16(2): 72-75.
Go to original source...
Go to PubMed...
- Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005; 54(6): 1615-1625.
Go to original source...
Go to PubMed...
- Brownlee M, Hirsch IB. Glycemic variability: A hemoglobin A1c-independent risk factor for diabetic complications. JAMA 2006; 295(14):1707-1708.
Go to original source...
Go to PubMed...
- Monnier L, Mas E, Ginet C et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. J JAMA. 2006; 295(14): 1681-1687.
Go to original source...
Go to PubMed...
- Ceriello A, Esposito K, Piconi L et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008; 57(5): 1349-1354.
Go to original source...
Go to PubMed...
- DCCT study group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329(14): 977-986.
Go to original source...
Go to PubMed...
- Kilpatrick ES, Rigby AS, Atkin SL. A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care 2008; 31(11): 2198-2202.
Go to original source...
Go to PubMed...
- Lachin JM, Genuth S, Nathan DM et al. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial - revisited. Diabetes 2008; 57(4): 995-1001.
Go to original source...
Go to PubMed...
- Bragd J, Adamson U, Bäcklund LBet al. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade Diabetes Metab 2008; 34(6 Pt 1): 612-616.
Go to original source...
Go to PubMed...
- Siegelaar SE, Kilpatrick ES, Rigby AS et al. Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: Data from the DCCT. Diabetologia 2009; 52(10): 2229-2232.
Go to original source...
Go to PubMed...
- Su G, Mi S, Tao H et al. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol 2011; 10: 19. Dostupné z DOI: <http://doi:10.1186/1475-2840-10-19>.
Go to original source...
Go to PubMed...
- van den Berghe G, Wouters P, Weekers Fet al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345(19): 1359-1367.
Go to original source...
Go to PubMed...
- Lanspa MJ, Dickerson J, Morris AH et al. Coefficient of glucose variation is independently associated with mortality in critically ill patients receiving intravenous insulin. Crit Care 2014; 18(2): R86.
Go to original source...
Go to PubMed...
- Šoupal J, Škrha J Jr, Fajmon M et al. Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control. Diabetes Technol Ther 2014; 16(4): 198-203.
Go to original source...
Go to PubMed...
- Garg SK, Schwartz S, Edelman SV. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 2004; 27(3): 734-738.
Go to original source...
Go to PubMed...
- Kilpatrick ES, Rigby AS, Goode K et al. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia 2007; 50(12): 2553-2561.
Go to original source...
Go to PubMed...
- Kovatchev BP, Cox DJ, Farhy LS et al. Episodes of severe hypoglycemia in type 1 diabetes are preceded and followed within 48 hours by measurable disturbances in blood glucose. J Clin Endocrinol Metab 2000; 85(11): 4287-4292.
Go to original source...
- Niskanen L, Virkamäki A, Hansen JB et al. Fasting plasma glucose variability as a marker of nocturnal hypoglycemia in diabetes: evidence from the PREDICTIVE study. Diabetes Res Clin Pract 2009; 86(2): e15-e18.
Go to original source...
Go to PubMed...
- Cryer PE. Hypoglycemia in type 1 diabetes mellitus. Endocrinol Metab Clin North Am 2010; 39(3): 641-654.
Go to original source...
Go to PubMed...
- Irace C, Fiorentino R, Carallo C et al. Exenatide improves glycemic variability assessed by continuous glucose monitoring in subjects with type 2 diabetes. Diabetes Technol Ther 2011; 13(12): 1261-1263.
Go to original source...
Go to PubMed...
- Yki-Järvinen H, Dressler A, Ziemen Met al. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group. Diabetes Care 2000; 23(8): 1130-1136.
Go to original source...
Go to PubMed...
- Evans M, Schumm-Draeger PM, Vora J et al. A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations. Diabetes Obes Metab 2011; 13(8): 677-684.
Go to original source...
Go to PubMed...
- Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ 2011; 343: d3805. Dostupné z DOI: <http://doi:10.1136/bmj.d3805>.
Go to original source...
Go to PubMed...
- Buse JB, Kudva YC, Battelino T et al. Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study. Diabetes Technol Ther 2012; 14(7): 644-647.
Go to original source...
Go to PubMed...
- Battelino T, Phillip M, Bratina N et al. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011; 34(4): 795-800.
Go to original source...
Go to PubMed...
- Kamble S, Weinfurt KP, Schulman KA et al. Patient time costs associated with sensor-augmented insulin pump therapy for type 1 diabetes: results from the STAR 3 randomized trial. Med Decis Making 2013; 33(2): 215-224.
Go to original source...
Go to PubMed...
- Elleri D, Allen JM, Biagioni M et al. Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes. Pediatr Diabetes 2012; 13(6): 449-453.
Go to original source...
Go to PubMed...
- Kumareswaran K, Elleri D, Allen JM, et al. Meta-analysis of overnight closed-loop randomized studies in children and adults with type 1 diabetes: the Cambridge cohort. J Diabetes Sci Technol 2011; 5(6): 1352-1362.
Go to original source...
Go to PubMed...
- Elleri D, Allen JM, Kumareswaran K et al. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care 2013; 36(4): 838-844.
Go to original source...
Go to PubMed...
- Danne T, Kordonouri O, Holder M et al. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther 2011; 13(11): 1129-1134.
Go to original source...
Go to PubMed...
- Choudhary P, Shin J, Wang Y et al. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care 2011; 34(9): 2023-2025.
Go to original source...
Go to PubMed...